Compounds and methods for treating alcohol disorder
AssigneeSophrosyne Pharmaceuticals Limited
InventorsLewis FELDBERG, Akram SABOUNI, Vincent Wing-Fai TAI
Life of this patent
Estimating the term…
Abstract
The disclosure is directed to, in part, compounds, or pharmaceutically acceptable salts or solvates thereof, for modulating the activity of aldehyde dehydrogenase such as ALDH2 and/or methods for treating and/or preventing an alcohol related disorder such as alcohol use disorder, alcohol induced disorder, alcohol abuse, alcohol dependence, alcohol intoxication, alcohol withdrawal, and the like and/or methods for reducing the amount of alcohol consumed, reducing alcoholic cravings, or increasing the percentage of no heavy drinking days for a subject with alcohol use disorder.
Claims14
A pharmaceutical composition comprising an enantiomeric excess of a compound having a formula of
- or a pharmaceutically acceptable salt or solvate thereof, and optionally a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.